Literature DB >> 7188625

Cisplatin-induced hemolysis.

E P Getaz, S Beckley, J Fitzpatrick, A Dozier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7188625     DOI： 10.1056/NEJM198002073020607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Changes in erythropoiesis due to radiation or chemotherapy as studied by flow cytometric determination of peripheral blood reticulocytes.

Authors:  H J Tanke; P H van Vianen; F M Emiliani; I Neuteboom; N de Vogel; A D Tates; E A de Bruijn; A T van Oosterom
Journal:  Histochemistry       Date:  1986

3.  Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin.

Authors:  G Cinollo; G Dini; E Franchini; E Lanino; F Sindaco; A Garaventa
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Clinical pharmacology of platinum complexes and their possible usefulness outside oncology.

Authors:  P N Plowman
Journal:  Agents Actions       Date:  1983-02

Review 5.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

6.  Cisplatin-associated anemia: an erythropoietin deficiency syndrome.

Authors:  P A Wood; W J Hrushesky
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 7.  [Cold agglutinin disease].

Authors:  R G Geissler; J Köbberling
Journal:  Klin Wochenschr       Date:  1988-04-01

Review 8.  Hypersensitivity and cross-reactivity to cisplatin and analogues.

Authors:  A A Shlebak; P I Clark; J A Green
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Haemolytic anaemia after cisplatin treatment.

Authors:  J A Levi; R S Aroney; D N Dalley
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20

10.  Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage.

Authors:  Shifeng Zhao; Xueqiao Wang; Xiaoqing Zheng; Xiu Liang; Zhigang Wang; Juanlian Zhang; Xudong Zhao; Shougang Zhuang; Qiuhui Pan; Fenyong Sun; Wenjun Shang; Jonathan Barasch; Andong Qiu
Journal:  Free Radic Biol Med       Date:  2021-07-21       Impact factor: 8.101
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.